LABORATOIRES ELLIOS BIO TEK : revenue, balance sheet and financial ratios

LABORATOIRES ELLIOS BIO TEK is a French company founded 31 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in BOULOGNE-BILLANCOURT (92100), this company of category PME shows in 2021 a revenue of 1.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRES ELLIOS BIO TEK (SIREN 401107529)
Indicator 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 1 228 337 € 831 407 € 1 089 180 € 988 577 € 1 010 389 € 851 285 €
Net income 81 784 € 176 118 € 43 646 € -56 801 € -91 422 € -39 457 € 13 016 € 33 244 €
EBITDA N/C N/C 72 617 € -47 416 € -48 037 € 54 045 € 66 901 € -19 287 €
Net margin N/C N/C 3.6% -6.8% -8.4% -4.0% 1.3% 3.9%

Revenue and income statement

In 2023, LABORATOIRES ELLIOS BIO TEK generates positive net income of 82 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 33 k€ -> 82 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

81 784 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 79%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

78.987%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

35.137%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

31.6%

Solvency indicators evolution
LABORATOIRES ELLIOS BIO TEK

Sector positioning

Debt ratio
78.99 2023
2021
2022
2023
Q1: 0.0
Med: 5.57
Q3: 50.77
Average

In 2023, the debt ratio of LABORATOIRES ELLIOS BIO TEK (78.99) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
35.14% 2023
2021
2022
2023
Q1: 13.47%
Med: 38.42%
Q3: 58.45%
Average +8 pts over 3 years

In 2023, the financial autonomy of LABORATOIRES ELLIOS BIO TEK (35.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
2.45 years 2021
2021
Q1: 0.0 years
Med: 0.01 years
Q3: 1.79 years
Watch

In 2021, the repayment capacity of LABORATOIRES ELLIOS BIO TEK (2.45) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 184.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

184.981

Liquidity indicators evolution
LABORATOIRES ELLIOS BIO TEK

Sector positioning

Liquidity ratio
184.98 2023
2021
2022
2023
Q1: 133.58
Med: 205.53
Q3: 329.15
Average -19 pts over 3 years

In 2023, the liquidity ratio of LABORATOIRES ELLIOS BIO TEK (184.98) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
1.12x 2021
2021
Q1: 0.0x
Med: 0.39x
Q3: 4.57x
Good

In 2021, the interest coverage of LABORATOIRES ELLIOS BIO TEK (1.1x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LABORATOIRES ELLIOS BIO TEK

Positioning of LABORATOIRES ELLIOS BIO TEK in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of LABORATOIRES ELLIOS BIO TEK is estimated at 67 186 € (range 25 571€ - 245 357€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
124 transactions
25k€ 67k€ 245k€
67 186 € Range: 25 571€ - 245 357€
NAF 5 all-time

Valuation method used

Net Income Multiple
81 784 € × 0.8x = 67 187 €
Range: 25 572€ - 245 358€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare LABORATOIRES ELLIOS BIO TEK with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about LABORATOIRES ELLIOS BIO TEK

What is the revenue of LABORATOIRES ELLIOS BIO TEK ?

The revenue of LABORATOIRES ELLIOS BIO TEK in 2021 is 1.2 M€.

Is LABORATOIRES ELLIOS BIO TEK profitable?

Yes, LABORATOIRES ELLIOS BIO TEK generated a net profit of 82 k€ in 2023.

Where is the headquarters of LABORATOIRES ELLIOS BIO TEK ?

The headquarters of LABORATOIRES ELLIOS BIO TEK is located in BOULOGNE-BILLANCOURT (92100), in the department Hauts-de-Seine.

Where to find the tax return of LABORATOIRES ELLIOS BIO TEK ?

The tax return of LABORATOIRES ELLIOS BIO TEK is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRES ELLIOS BIO TEK operate?

LABORATOIRES ELLIOS BIO TEK operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.